A myasthenic syndrome with congenital paucity of secondary synaptic clefts: CPSC Syndrome

Two cases of a newly recognized myasthenic syndrome were investigated (CPSC syndrome). The course of the disease was observed for periods of 6 and 3 years. In infancy, exacerbations of the symptoms occurred during febrile illness, but thereafter the clinical course was stable and the children appeared to be only slightly handicapped. Biopsies were taken from the intercostal muscle in both patients. Microelectrode studies revealed small Mepp amplitudes. Light microscopy demonstrated predominance of type I fibers and focal type‐grouping. There was a lowered cholinesterase activity and frequent branching of preterminal axons. Electron microscopy revealed that there were few, if any, folds of the postsynaptic membrane and that there were no signs of degeneration. Methods for localization of acetylcholine receptors (AChR) revealed a deficiency and altered distribution of AChRs at these postsynaptic membranes and the occurrence of extrajunctional AChRs in some muscle fibers. It is concluded that the syndrome is a clinicopathological entity, characterized morphologically by a congenital paucity of secondary synaptic clefts (CPSC syndrome).

[1]  P. Molenaar,et al.  A Congenital Myasthenic Disorder with Paucity of Secondary Synaptic Clefts: Deficiency and Altered Distribution of Acetylcholine Receptors a , 1987, Annals of the New York Academy of Sciences.

[2]  F. Jennekens,et al.  Immunohistochemical localization of acetylcholine receptors at human endplates using a monoclonal antibody. , 1987, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[3]  G. Hageman,et al.  Muscle weakness and congenital contractures in a case of congenital myasthenia. , 1986, Journal of pediatric orthopedics.

[4]  P. Barth,et al.  Paucity of secondary synaptic clefts in a case of congenital myasthenia with multiple contractures: ultrastructural morphology of a developmental disorder. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[5]  J. Albers,et al.  Abnormal neuromuscular transmission in an infantile myasthenic syndrome , 1984, Annals of neurology.

[6]  J. Connolly.  Role of the cytoskeleton in the formation, stabilization, and removal of acetylcholine receptor clusters in cultured muscle cells , 1984, The Journal of cell biology.

[7]  N. Hirokawa,et al.  Internal and external differentiations of the postsynaptic membrane at the neuromuscular junction , 1982, Journal of neurocytology.

[8]  A. Engel,et al.  A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine‐induced ion channel , 1982, Annals of neurology.

[9]  M. Kawabuchi.  Neostigmine Myopathy Is a Calcium Ion‐Mediated Myopathy Initially Affecting the Motor End‐plate , 1982, Journal of neuropathology and experimental neurology.

[10]  A. Trautmann,et al.  Congenital myasthenia: End‐plate acetylcholine receptors and electrophysiology in five cases , 1981, Muscle & nerve.

[11]  J. Adams.  Heavy metal intensification of DAB-based HRP reaction product. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  N. Murray,et al.  Alterations in the number and affinity of junctional acetylcholine receptors in a myopathy with tubular aggregates. A newly recognized receptor defect. , 1981, Brain : a journal of neurology.

[13]  A. Fidziańska.  Human Ontogenesis: II. Development of the Human Neuromuscular Junction , 1980, Journal of neuropathology and experimental neurology.

[14]  L. Smit,et al.  Arthrogryposis Multiplex Congenita due to Congenital Myasthenia , 1980, Developmental Medicine & Child Neurology.

[15]  W. Hoffman,et al.  Polyneuropathy, alopecia areata, and chronic lymphocytic thyroiditis , 1979, Neurology.

[16]  R. Miledi,et al.  Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis. , 1978, Brain : a journal of neurology.

[17]  A. Pestronk,et al.  Motor nerve sprouting and acetylcholine receptors. , 1978, Science.

[18]  J. Sanes,et al.  Cholinesterase is associated with the basal lamina at the neuromuscular junction , 1978, Nature.

[19]  A. Pestronk,et al.  A new stain for quantitative measurement of sprouting at neuromuscular junctions , 1978, Muscle & nerve.

[20]  J. Mazurkiewicz,et al.  Cytochemical localization of acetylcholine receptors at the neuromuscular junction by means of horseradish peroxidase-labelled α-bungarotoxin , 1977, Brain Research.

[21]  A. Engel,et al.  A new myasthenic syndrome with end‐plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release , 1977, Annals of neurology.

[22]  A. Engel,et al.  Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model , 1977, Neurology.

[23]  W. Engel,et al.  Extrajunctional acetylcholine receptors. Alterations in human and experimental neuromuscular diseases. , 1976, Archives of neurology.

[24]  C. Coërs,et al.  MORPHOLOGICAL AND HISTOCHEMICAL CHANGES OF MOTOR UNITS IN MYASTHENIA * , 1976, Annals of the New York Academy of Sciences.

[25]  A. Pestronk,et al.  Effect of muscle disuse on acetylcholine receptors , 1976, Nature.

[26]  E. Barnard,et al.  Distribution and density of cholinergic receptors at the motor endplates of a denervated mouse muscle , 1975, Experimental Neurology.

[27]  Z. Vogel,et al.  Immunoperoxidase staining of α-bungarotoxin binding sites in muscle endplates shows distribution of acetylcholine receptors , 1975, Nature.

[28]  C. Chang,et al.  Influence of chronic neostigmine treatment on the number of acetylcholine receptors and the release of acetylcholine from the rat diaphragm , 1973, The Journal of physiology.